Literature DB >> 29743242

Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.

Uri Mbonye1, Benlian Wang2, Giridharan Gokulrangan2, Wuxian Shi2, Sichun Yang2, Jonathan Karn3.   

Abstract

The HIV trans-activator Tat recruits the host transcription elongation factor P-TEFb to stimulate proviral transcription. Phosphorylation of Thr-186 on the activation loop (T-loop) of cyclin-dependent kinase 9 (CDK9) is essential for its kinase activity and assembly of CDK9 and cyclin T1 (CycT1) to form functional P-TEFb. Phosphorylation of a second highly conserved T-loop site, Ser-175, alters the competitive binding of Tat and the host recruitment factor bromodomain containing 4 (BRD4) to P-TEFb. Here, we investigated the intracellular mechanisms that regulate these key phosphorylation events required for HIV transcription. Molecular dynamics simulations revealed that the CDK9/CycT1 interface is stabilized by intramolecular hydrogen bonding of pThr-186 by an arginine triad and Glu-96 of CycT1. Arginine triad substitutions that disrupted CDK9/CycT1 assembly accumulated Thr-186-dephosphorylated CDK9 associated with the cytoplasmic Hsp90/Cdc37 chaperone. The Hsp90/Cdc37/CDK9 complex was also present in resting T cells, which lack CycT1. Hsp90 inhibition in primary T cells blocked P-TEFb assembly, disrupted Thr-186 phosphorylation, and suppressed proviral reactivation. The selective CDK7 inhibitor THZ1 blocked CDK9 phosphorylation at Ser-175, and in vitro kinase assays confirmed that CDK7 activity is principally responsible for Ser-175 phosphorylation. Mutation of Ser-175 to Lys had no effect on CDK9 kinase activity or P-TEFb assembly but strongly suppressed both HIV expression and BRD4 binding. We conclude that the transfer of CDK9 from the Hsp90/Cdc37 complex induced by Thr-186 phosphorylation is a key step in P-TEFb biogenesis. Furthermore, we demonstrate that CDK7-mediated Ser-175 phosphorylation is a downstream nuclear event essential for facilitating CDK9 T-loop interactions with Tat.
© 2018 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  7SK snRNP; CDK activation loop; Cdc37; HIV latency; P-TEFb; Tat; bromodomain-containing protein 4 (BRD4); heat-shock protein 90 (Hsp90); human immunodeficiency virus (HIV); post-translational modification (PTM); proteomics; super-elongation complex; transcription elongation factor

Mesh:

Substances:

Year:  2018        PMID: 29743242      PMCID: PMC6028954          DOI: 10.1074/jbc.RA117.001347

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

1.  AMBER force-field parameters for phosphorylated amino acids in different protonation states: phosphoserine, phosphothreonine, phosphotyrosine, and phosphohistidine.

Authors:  Nadine Homeyer; Anselm H C Horn; Harald Lanig; Heinrich Sticht
Journal:  J Mol Model       Date:  2005-10-21       Impact factor: 1.810

2.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

3.  HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription.

Authors:  Nanhai He; Min Liu; Joanne Hsu; Yuhua Xue; Seemay Chou; Alma Burlingame; Nevan J Krogan; Tom Alber; Qiang Zhou
Journal:  Mol Cell       Date:  2010-05-14       Impact factor: 17.970

4.  NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.

Authors:  R Q Cron; S R Bartz; A Clausell; S J Bort; S J Klebanoff; D B Lewis
Journal:  Clin Immunol       Date:  2000-03       Impact factor: 3.969

5.  Crystal structure of HIV-1 Tat complexed with human P-TEFb.

Authors:  Tahir H Tahirov; Nigar D Babayeva; Katayoun Varzavand; Jeffrey J Cooper; Stanley C Sedore; David H Price
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 6.  Latency reversal and viral clearance to cure HIV-1.

Authors:  David M Margolis; J Victor Garcia; Daria J Hazuda; Barton F Haynes
Journal:  Science       Date:  2016-07-22       Impact factor: 47.728

7.  The CDK Network: Linking Cycles of Cell Division and Gene Expression.

Authors:  Robert P Fisher
Journal:  Genes Cancer       Date:  2012-11

8.  Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex.

Authors:  N J Keen; M J Gait; J Karn
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

9.  Heat shock protein 90 controls HIV-1 reactivation from latency.

Authors:  Ian Anderson; Jun Siong Low; Stuart Weston; Michael Weinberger; Alexander Zhyvoloup; Aksana A Labokha; Gianmarco Corazza; Russell A Kitson; Christopher J Moody; Alessandro Marcello; Ariberto Fassati
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-31       Impact factor: 11.205

10.  Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex.

Authors:  Sebastian Biglione; Sarah A Byers; Jason P Price; Van Trung Nguyen; Olivier Bensaude; David H Price; Wendy Maury
Journal:  Retrovirology       Date:  2007-07-11       Impact factor: 4.602

View more
  22 in total

1.  The Covalent CDK7 Inhibitor THZ1 Potently Induces Apoptosis in Multiple Myeloma Cells In Vitro and In Vivo.

Authors:  Yu Zhang; Liang Zhou; Dipankar Bandyopadhyay; Kanika Sharma; Alexander Joseph Allen; Maciej Kmieciak; Steven Grant
Journal:  Clin Cancer Res       Date:  2019-07-29       Impact factor: 12.531

2.  The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency.

Authors:  Luisa Mori; Katharine Jenike; Yang-Hui Jimmy Yeh; Benoît Lacombe; Chuan Li; Adam Getzler; Sonia Mediouni; Michael Cameron; Matthew Pipkin; Ya-Chi Ho; Bertha Cecilia Ramirez; Susana Valente
Journal:  J Virol       Date:  2020-11-25       Impact factor: 5.103

Review 3.  Cure and Long-Term Remission Strategies.

Authors:  Luisa Mori; Susana T Valente
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Targeting cyclin-dependent kinase 9 in cancer therapy.

Authors:  Yi-Li Shen; Yan-Mao Wang; Ya-Xin Zhang; Shen-Jie Ma; Le-He Yang; Cheng-Guang Zhao; Xiao-Ying Huang
Journal:  Acta Pharmacol Sin       Date:  2021-11-22       Impact factor: 7.169

Review 5.  Targeting HIV-1 proviral transcription.

Authors:  Alex Olson; Binita Basukala; Wilson W Wong; Andrew J Henderson
Journal:  Curr Opin Virol       Date:  2019-08-29       Impact factor: 7.121

6.  Estrogen receptor-1 is a key regulator of HIV-1 latency that imparts gender-specific restrictions on the latent reservoir.

Authors:  Biswajit Das; Curtis Dobrowolski; Benjamin Luttge; Saba Valadkhan; Nicolas Chomont; Rowena Johnston; Peter Bacchetti; Rebecca Hoh; Monica Gandhi; Steven G Deeks; Eileen Scully; Jonathan Karn
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-30       Impact factor: 11.205

7.  Entry of Polarized Effector Cells into Quiescence Forces HIV Latency.

Authors:  Curtis Dobrowolski; Saba Valadkhan; Amy C Graham; Meenakshi Shukla; Angela Ciuffi; Amalio Telenti; Jonathan Karn
Journal:  mBio       Date:  2019-03-26       Impact factor: 7.867

Review 8.  Targeting CDK9 for Anti-Cancer Therapeutics.

Authors:  Ranadip Mandal; Sven Becker; Klaus Strebhardt
Journal:  Cancers (Basel)       Date:  2021-05-01       Impact factor: 6.639

9.  Genome-wide identification of cyclin-dependent kinase (CDK) genes affecting adipocyte differentiation in cattle.

Authors:  Cuili Pan; Zhaoxiong Lei; Shuzhe Wang; Xingping Wang; Dawei Wei; Xiaoyan Cai; Zhuoma Luoreng; Lei Wang; Yun Ma
Journal:  BMC Genomics       Date:  2021-07-12       Impact factor: 3.969

Review 10.  The Cytomegalovirus Protein Kinase pUL97:Host Interactions, Regulatory Mechanisms and Antiviral Drug Targeting.

Authors:  Mirjam Steingruber; Manfred Marschall
Journal:  Microorganisms       Date:  2020-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.